Premier Fund Managers’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,970
Closed -$196K 218
2023
Q3
$196K Sell
13,970
-20,495
-59% -$323K 0.01% 190
2023
Q2
$778K Sell
34,465
-11,710
-25% -$247K 0.03% 171
2023
Q1
$959K Sell
46,175
-20,006
-30% -$450K 0.04% 176
2022
Q4
$1.2M Sell
66,181
-65,000
-50% -$1.34M 0.05% 163
2022
Q3
$3.11M Hold
131,181
0.23% 53
2022
Q2
$1.91M Hold
131,181
0.08% 138
2022
Q1
$3.01M Hold
131,181
0.11% 140
2021
Q4
$4.91M Hold
131,181
0.16% 121
2021
Q3
$5.51M Hold
131,181
0.18% 128
2021
Q2
$5.7M Sell
131,181
-44,742
-25% -$1.58M 0.19% 125
2021
Q1
$6.33M Buy
+175,923
New +$6.96M 0.25% 106

Other funds holding BLFS

Premier Fund Managers's BLFS Position: Q4 2023 in Review

Premier Fund Managers sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 13,970 shares — an estimated $196K sold.

Premier Fund Managers first reported a position in BLFS in Q1 2021 and held it in 11 quarters. The position peaked at $6.33M in Q1 2021. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • Premier Fund Managers reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • Premier Fund Managers sold 13,970 BioLife Solutions shares in Q4 2023, an estimated $196K.
  • Premier Fund Managers first reported a position in BioLife Solutions in Q1 2021 and held it in 11 quarters.
  • Premier Fund Managers's BioLife Solutions position peaked at $6.33M in Q1 2021.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on Premier Fund Managers's 13F filing for Q4 2023, filed 13 Feb 2024.